Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock
HENDERSON, Nev., Oct. 19, 2023 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, announces the publication of a clinical paper1 which shows that Volition’s Nu.Q® NETs test is a promising biomarker for the evaluation of disease severity in septic shock patients and could play an important role in sepsis prognosis.
Read MoreMeasuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock
Partly cloudy skies. Slight chance of a rain shower. High near 70F. Winds WNW at 10 to 20 mph..
Read More